Search results for abx831013

Lorvotuzumab, Abbexa, abx831013

Lorvotuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting NCAM1/CD56, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Lorvotuzumab mertansine has been used in trials studying the treatment of SCLC, Leukemia, Ovarian Cancer, Multiple Myeloma, and Merkel Cell Carcinoma, among others.